24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
Kids Raised by Grandparents More Likely to Pile on Pounds: StudyKeep Your Kids Safe, Warm in Wintertime FunHow to Dispel Your Child's Fears About the New CoronavirusDiabetes Among U.S. Young, Especially Asians, Continues to ClimbMom-to-Be's Cosmetics Chemicals Could Lead to Heavier BabyMeds May Not Prevent Migraines in KidsAHA News: For Kids With Heart Defects, the Hospital Near Mom May Matter1 in 4 Gets Unneeded Antibiotics at Children's HospitalsVitamin D in Pregnancy Doesn't Curb Kids' AsthmaFirst Drug Approved for Treatment of Peanut Allergy in ChildrenWhat's the Best Treatment for a Child's Broken Bone?Are Antibiotics a Recipe for Obesity in Childhood?This Year's Flu Season Taking Deadly Aim at KidsWhy Are Fewer U.S. Kids Going to Pediatricians?Severe Deprivation in Childhood Has Lasting Impact on Brain SizeHealth Tip: What Your Child Can do About BullyingWildfires Send Kids to ERs for Breathing ProblemsTV Can Be a Good Influence on Kids' Eating HabitsWould Tighter Swimming Rules at Public Beaches, Lakes and Rivers Save Lives?U.S. Doctors Often Test, Treat Kids UnnecessarilyHealth Tip: Safety Steps if Your Child is Home AloneHealth Tip: Help Your Child Safely Lose WeightAmericans Need to Tackle Youth Obesity: U.S. Task ForceGenes, Family Are Key Predictors of School SuccessKids' 'Microbiome' May Play Key Role in AsthmaA Puppy in Santa's Sack? Probably Not, Say ParentsMore Kids, Teens Landing in ERs After Opioid OverdosesGetting Active Helps Kids' Hearts, Even in the ObeseWhen Does Your Child's Flu Merit an ER Visit?Health Tip: Managing Hearing Loss in ChildrenHealth Tip: Is My Child Too Sick to Go to School?Differences Found in Brains of Kids Born to Depressed ParentsSecondhand Smoke Starts Kids on Path to Heart Disease: StudyHealth Tip: Choosing a PediatricianMany Kids Traveling Overseas Aren't Vaccinated Against MeaslesCould Obesity Alter a Child's Brain Structure?Dramatic Rise in Eye Injuries From BB and Paintball GunsTwo-Thirds of Child Abuse Survivors Do Well as AdultsAHA News: Serious Heart Defects Increase Heart Failure Risk in Early AdulthoodMore U.S. Kids Are Shunning Sweetened DrinksAs Disease Outbreaks Tied to 'Anti-Vaxxers' Rise, States Take Action'Don't Give Up:' Parents' Intuition Spots a Rare Illness Before Doctors DoFDA Approves First Contact Lens That Slows Myopia ProgressionStereotypes About Girls and Math Don't Add Up, Scans ShowStudies Confirm HPV Shot Is SafeThese Sports Are Most Likely to Send Young Americans to the ERNature Nurtures KidsClimate Change Will Hurt Kids Most, Report WarnsTough Childhoods Can Leave a Lifetime of Harm, Experts SayMany U.S. Parents Can't Find a Psychiatrist to Help Their Child
Questions and AnswersLinks
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Child Development & Parenting: Infants (0-2)
Child Development & Parenting: Early (3-7)

FDA Approves Victoza Injection for Children 10 Years and Older


HealthDay News
Updated: Jun 18th 2019

new article illustration

TUESDAY, June 18, 2019 (HealthDay News) -- Victoza (liraglutide) injection is now approved to treat type 2 diabetes in children 10 years and older, the U.S. Food and Drug Administration announced.

Approved to treat type 2 diabetes in adults in 2010, Victoza is the first noninsulin drug to be approved to treat type 2 diabetes in children since metformin in 2000. Victoza's labeling states that the injection is not a substitute for insulin and is not indicated for patients with type 1 diabetes or those with diabetic ketoacidosis. Dosage of Victoza in children should start at 0.6 mg daily for at least one week. The manufacturer's prescribing information indicates that if additional glycemic control is required, the dose should be increased to 1.2 mg daily, and then to 1.8 mg daily after at least one week of treatment with the 1.2-mg daily dose if additional control is still required.

Approval of Victoza in children aged 10 years and older was based on several placebo-controlled trials in adults and one placebo-controlled trial in children. In the trial of 134 children aged 10 years and older, at 26-week follow-up, HbA1c levels reduced to less than 7 percent for approximately 64 percent of children treated with Victoza compared with 37 percent of children treated with placebo. Researchers found similar results when patients were also taking insulin simultaneously.

Although Victoza has been indicated to reduce the risk for major adverse cardiovascular events in adults with type 2 diabetes, the FDA notes that the drug's effect on major adverse cardiovascular events in children has not been studied, and it is therefore not indicated to reduce the risk for these events in children. Children aged 10 years and older who are taking Victoza have an increased risk for hypoglycemia even without additional therapies for diabetes. Due to an increased risk for thyroid C-cell tumors, Victoza is contraindicated in patients who have had medullary thyroid carcinoma, those with family members who have had medullary thyroid carcinoma, and patients with multiple endocrine neoplasia syndrome type 2.

Approval of Victoza was granted to Novo Nordisk.

More Information